Study of a new tablet for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study tests an experimental tablet to see if it can help control blood sugar in people with type 2 diabetes. It may be an option for those who are already on metformin or managing with diet and exercise.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have had type 2 diabetes for at least 3 months.
- You have been on a stable dose of metformin (at least 1000 mg per day) for at least 8 weeks, or you control your blood sugar with diet and exercise alone.
- Your A1c (average blood sugar over 3 months) is between 7.5% and 11.0% at screening.
- Your body mass index (BMI) is between 22.5 and 40.
- Your weight has been stable (not changing by more than 5%) for the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication called HM15275 to help control blood sugar in people with type 2 diabetes. The trial will check if the medication works well and is safe when added to diet, exercise, or metformin treatment.
This trial tests a new once-daily tablet (elecoglipron) against a placebo to see if it can help improve blood sugar control in adults with type 2 diabetes who are already on insulin. It may offer an additional treatment option to help manage your diabetes.
This study tests if a new medicine (elecoglipron) combined with dapagliflozin is safe and works better for adults with type 2 diabetes that isn't well controlled by diet or other medications.
This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.
This study tests whether a new tablet called HRS9531 helps people with type 2 diabetes control their blood sugar better. You would take it along with your current diabetes management (lifestyle changes or metformin) over several months.
This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.
Hear when a new Type 2 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.